|
IQVIA™ Real-World Insights Bibliography
| Modeling cost-effectiveness of drug treatments for severe chronic non-cancer pain in Portugal |
| Author(s): Obradovic M1, Hertel N2, Ikenberg R3, Gouveia M4, Liedgens H1
|
| Affiliations(s): 1Grünenthal GmbH, Aachen, Germany, 2IMS Health, London, UK, 3IMS Health GmbH Und Co. Ohg, Nürnberg, Germany, 4Catholic University of Portugal, Lisbon, Portugal |
Publication(s): ISPOR 14th Annual European Congress, 5th - 8th November, Madrid, Spain
|
| Document Type(s): Poster, |
| Countries: Portugal, |
| Click here for the abstract |
C:
Y: |
Neurological disorders,
2011 |
|
L:
A: |
English
Cost effectiveness, |
|
 |
| |
| |
| Cost-effectiveness of transferring Type-2 Diabetic patients from Neutral Protamine Hagedorn (NPH) To Detemir in Portugal settings |
| Author(s): Carvalho D1, Lindner L2, Kozarzewski M3 |
| Affiliations(s): 1São João Hospital, Porto, Porto, Portugal, 2IMS Health, Barcelona, Cataluña, Spain, 3Novo Nordisk Portugal, Lisboa, Lisboa, Portugal |
Publication(s): ISPOR 14th Annual European Congress, 5th - 8th November, Madrid, Spain
|
| Document Type(s): Poster, |
| Countries: Portugal, |
| Click here for the abstract |
C:
Y: |
Diabetes,
2011 |
|
L:
A: |
English
Cost effectiveness, |
|
|
| |
| |
| Modeling cost-effectiveness of drug treatments for severe chronic non-cancer pain in Portugal |
| Author(s): Obradovic M.1, Ikenberg R.2, Hertel N.3, Gouveia M.4, Liedgens H.1 |
| Affiliations(s): 1 Grünenthal GmbH, Aachen, Germany, 2 IMS Consulting Group, Nuremberg, Germany, 3 IMS Consulting Group, London, UK, 4 Católica School of Business and Economics, Lisbon, Portugal |
Publication(s): ISPOR 14th Annual European Congress, 5th - 8th November, Madrid, Spain
|
| Document Type(s): Poster, |
| Countries: Portugal, |
C:
Y: |
Pricing and reimbursement,
2011 |
|
L:
A: |
English
Cost effectiveness, |
|
|
| |
| |
| Cost-effectiveness of Exenatide Versus Insulin Glargine and Versus Biphasic Insulin Aspart for the Treatment of Type 2 Diabetes in Portugal: A Long-term Health Economic Analysis |
| Author(s): Palmer JL1, Pinto CG2, Duarte R3, Miguel LS2, Gregor Z4 |
| Affiliations(s): 1 IMS Health, Basel, Switzerland 2 Centro de Investigação sobre Economia Portuguesa, Lisbon, Portugal 3 Associação Protectora dos Diabéticos, Lisbon, Portugal 4 Eli Lilly and Company, European Health Outcomes Research, Prague, Czech Republic |
Publication(s): ISPOR 13thAnnual European Congress; Prague, Czech Republic; November 6?9, 2010
|
| Document Type(s): Manuscript in preparation, |
| Countries: Portugal, |
C:
Y: |
Diabetes,
2010 |
|
L:
A: |
English
Cost effectiveness, |
|
|
| |
| |
| Custo do tratamento do cancro em Portugal. [Cost of cancer care in Portugal]. |
| Author(s): Araújo A1, Barata F2, Barroso S3, Cortes P4, Damasceno M5, Parreira A6, Espírito Santo J7, Teixeira E8, Pereira R9. |
| Affiliations(s): 1 Serviço de Oncologia. Instituto Português de Oncologia. Porto
2 Serviço de Pneumologia. Centro Hospitalar de Coimbra. Coimbra
3 Serviço de Oncologia. Hospital do Espírito Santo. Évora
4 Serviço de Oncologia. Hospital de Santa Maria. Lisboa
5 Serviço de Oncologia. Hospital de São João. Porto
6 Departamento de Hematologia. Instituto Português de Oncologia. Lisboa
7 Serviço de Oncologia. Hospital de Nossa Senhora do Rosário. Barreiro
8 Serviço de Pneumologia, Hospital de Santa Maria. Lisboa
9 IMS Health Portugal, HEOR |
Publication(s): Acta Med Port 2009; 22: 525-536.
|
| Document Type(s): Article, Manuscript in preparation, |
| Countries: Portugal, |
C:
Y: |
Oncology,
2009 |
|
L:
A: |
Spanish
, |
|
|
| |
| |
 3 of 3
|
|
